Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of baclofen and proton pump inhibitors in gastroesophageal reflux disease
IRCT20210308050634N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of baclofen in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Islamic Azad University. Started May 2021; status: completed.
02
Drugs
baclofen
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on IRCT20210308050634N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210308050634N1.